Search hospitals
>
Missouri
>
Cape Girardeau
Saint Francis Medical Center
Claim this profile
Cape Girardeau, Missouri 63703
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
430 reported clinical trials
5 medical researchers
Summary
Saint Francis Medical Center is a medical facility located in Cape Girardeau, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Francis Medical Center is involved with conducting 430 clinical trials across 472 conditions. There are 5 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Robert H. Stone, RRT, and Stephen S. Bricknell, RRT.
Area of expertise
Breast Cancer
Saint Francis Medical Center has run 76 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Saint Francis Medical Center has run 74 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Bryan A. Faller
Crossroads Cancer Center
7 years of reported clinical research
James L. Wade
Decatur Memorial Hospital
4 years of reported clinical research
Robert H. Stone, RRT
Saint Francis Medical Center
17 years of reported clinical research
Stephen S. Bricknell, RRT
Saint Francis Medical Center
17 years of reported clinical research
Clinical Trials running at Saint Francis Medical Center
Lung Cancer
Bladder Cancer
Prostate Cancer
Breast Cancer
Kidney Cancer
Breast cancer
Cancer
Bladder Carcinoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Radiotherapy
for Lung Cancer
This study is being done to answer the following question: Can the chance of lung cancer growing or spreading be lowered by adding targeted radiotherapy to the usual combination of drugs? This study is being done to find out if this approach is better or worse than the usual approach for lung cancer. The usual approach is defined as the care most people get for non-small cell lung cancer.
Recruiting
2 awards
Phase 3
4 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Francis Medical Center?
Saint Francis Medical Center is a medical facility located in Cape Girardeau, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Francis Medical Center is involved with conducting 430 clinical trials across 472 conditions. There are 5 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Robert H. Stone, RRT, and Stephen S. Bricknell, RRT.
Where is Saint Francis Medical Center located?
**Saint Francis Medical Center** - **Address:** 211 Saint Francis Drive, Cape Girardeau, MO 63703. - **Directions:** - From Missouri: Take Interstate 55 to exit 96, then head east on William Street/Route K. - From Illinois: Take Highway 146 to Highway 74, then turn right onto Mt. Auburn Road.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Saint Francis Medical Center, contact Customer Service at 573-331-5217 or 1-866-304-3071 (Monday – Friday, 8:00 am – 5:30 pm), request assistance online, or visit the Saint Francis Business Office. For insurance inquiries, call the provided numbers or visit the business office during operating hours.
What insurance does Saint Francis Medical Center accept?
Saint Francis Medical Center accepts a broad spectrum of insurance plans, including commercial insurance plans like Aetna Health Incorporated, Anthem Blue Cross Blue Shield, Cigna Health Care, Coventry Health Care, and UnitedHealthcare. They also welcome Medicaid plans from Missouri, Illinois, and Kentucky, in addition to Medicare and Medicare Advantage plans. Patients are advised to verify coverage with their insurance carrier prior to receiving services and bring their insurance card to appointments for accurate billing.
What awards or recognition has Saint Francis Medical Center received?
Saint Francis Medical Center, located in Cape Girardeau, Missouri, is nationally recognized for its excellence in clinical trial enrollments via the National Cancer Institute's NCORP. The hospital is acclaimed for its major service lines: neurosciences, cardiovascular services, cancer services, orthopedic services, and radiology, highlighting its commitment to quality and innovation in healthcare.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.